1 documents found
Information × Registration Number 0203U000201, 0100U002737 , R & D reports Title To eleborate the program of treatment myelofibrosis with myeloid metaplasia and polycythaemia using native alfa-2-interferon (laferon). popup.stage_title Head Tretyk N.N., Доктор медичних наук Registration Date 23-01-2003 Organization Kiev Research Institute of Haematolojy and Blood Transfusion popup.description2 Blood of patients with myelofibrosis with myeloid metaplasia and polycythaemia was examined using clinical, hematological, biochemical, immunological and morphological methods. Program of medical treatment of myelofibrosis with myeloid metaplasia and polycythaemia vera with alfa-2- interferon (laferon) was elaborated. In comparison to standard chemotherapy treatmens program, the patients showed a significant improvement of clinical, biochemical and immunological characteristics. Medicine. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Head: Tretyk N.N.. To eleborate the program of treatment myelofibrosis with myeloid metaplasia and polycythaemia using native alfa-2-interferon (laferon).. (popup.stage: ). Kiev Research Institute of Haematolojy and Blood Transfusion. № 0203U000201
1 documents found

Updated: 2026-03-23